- Home
- INSP vs TMDX Comparison
INSP vs TMDX Comparison
Compare INSP & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSP
- TMDX
- Stock Information
- Founded
- INSP 2007
- TMDX 1998
- Country
- INSP United States
- TMDX United States
- Employees
- INSP N/A
- TMDX N/A
- Industry
- INSP Medical/Dental Instruments
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- INSP Health Care
- TMDX Health Care
- Exchange
- INSP Nasdaq
- TMDX Nasdaq
- Market Cap
- INSP 3.8B
- TMDX 3.9B
- IPO Year
- INSP 2018
- TMDX 2019
- Fundamental
- Price
- INSP $86.85
- TMDX $114.30
- Analyst Decision
- INSP Buy
- TMDX Buy
- Analyst Count
- INSP 16
- TMDX 11
- Target Price
- INSP $139.40
- TMDX $130.73
- AVG Volume (30 Days)
- INSP 1.3M
- TMDX 1.0M
- Earning Date
- INSP 11-03-2025
- TMDX 10-29-2025
- Dividend Yield
- INSP N/A
- TMDX N/A
- EPS Growth
- INSP 34.77
- TMDX 170.70
- EPS
- INSP 1.48
- TMDX 2.54
- Revenue
- INSP $882,622,000.00
- TMDX $566,354,000.00
- Revenue This Year
- INSP $14.83
- TMDX $38.84
- Revenue Next Year
- INSP $14.44
- TMDX $20.46
- P/E Ratio
- INSP $58.50
- TMDX $45.35
- Revenue Growth
- INSP 16.81
- TMDX 41.20
- 52 Week Low
- INSP $70.77
- TMDX $55.00
- 52 Week High
- INSP $216.01
- TMDX $145.50
- Technical
- Relative Strength Index (RSI)
- INSP 57.50
- TMDX 40.85
- Support Level
- INSP $79.61
- TMDX $115.21
- Resistance Level
- INSP $92.01
- TMDX $125.57
- Average True Range (ATR)
- INSP 4.04
- TMDX 7.65
- MACD
- INSP 1.19
- TMDX -1.72
- Stochastic Oscillator
- INSP 74.03
- TMDX 12.41
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.